These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26489545)

  • 61. [Serious concerns about multimodal treatments of cervical cancer].
    Morice P
    Bull Cancer; 2016; 103(7-8):610-1. PubMed ID: 27373594
    [No Abstract]   [Full Text] [Related]  

  • 62. Oral cancer: comprehending the condition, causes, controversies, control and consequences. 12. Radiotherapy and chemotherapy.
    Nutting CM; Scully C
    Dent Update; 2011 Dec; 38(10):717-9. PubMed ID: 22408897
    [No Abstract]   [Full Text] [Related]  

  • 63. Relative dose intensity and overall treatment time in older patients with cervical cancer treated with concurrent chemoradiotherapy.
    Nakamura R; Shimoji Y; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Ooyama T; Kudaka W; Mekaru K; Aoki Y
    J Geriatr Oncol; 2021 Mar; 12(2):332-334. PubMed ID: 32938543
    [No Abstract]   [Full Text] [Related]  

  • 64. Analysis of symptom clusters in Chinese cervical cancer patients undergoing radiotherapy, chemoradiotherapy, or postoperative chemoradiotherapy.
    Wang CL; Wu WY; Lou HM; Wang HM; Liang GM; Xia LY; Fang Y; Yin ZM
    Eur J Gynaecol Oncol; 2017; 38(3):398-403. PubMed ID: 29693881
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Ⅲ.The Current Status and Future Perspective of Chemotherapy, Targeted Therapy and Immunotherapy for Cervical Cancer].
    Yabuno A; Hasegawa K
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):242-246. PubMed ID: 32381956
    [No Abstract]   [Full Text] [Related]  

  • 66. Barrel-shaped cervical carcinoma.
    Girtanner RE
    Am J Obstet Gynecol; 1977 Jan; 127(2):216-7. PubMed ID: 831511
    [No Abstract]   [Full Text] [Related]  

  • 67. Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports.
    Wakayama A; Kudaka W; Nakasone T; Taira Y; Aoki Y
    Gynecol Oncol Rep; 2017 Aug; 21():81-83. PubMed ID: 28761924
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiparameter MRI and Clinical Factors for Predicting Early Response to Chemoradiotherapy in Cervical Cancer.
    Javadi S; Kundra V
    Radiol Imaging Cancer; 2021 Jan; 3(1):e209038. PubMed ID: 33778762
    [No Abstract]   [Full Text] [Related]  

  • 69. Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer.
    Zsiros E; Tsuji T; Odunsi K
    J Clin Oncol; 2015 May; 33(14):1521-2. PubMed ID: 25847926
    [No Abstract]   [Full Text] [Related]  

  • 70. Future Perspectives for Uterine Cervical Cancer Treatment based on Integrative Genomic and Molecular Characterizations.
    Tiezzi DG
    Rev Bras Ginecol Obstet; 2017 Apr; 39(4):147-148. PubMed ID: 28351082
    [No Abstract]   [Full Text] [Related]  

  • 71. Report 89.
    J ICRU; 2013 Apr; 13(1-2):NP. PubMed ID: 27335498
    [No Abstract]   [Full Text] [Related]  

  • 72. (Chemo)Radiotherapy-Immunotherapy Combinations: Time to Get Tailored?
    Mondini M; Deutsch E
    Clin Cancer Res; 2021 Jul; 27(14):3815-3817. PubMed ID: 33986023
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reply to S. Acharya.
    Chopra S; Kannan S; Gupta S
    J Clin Oncol; 2022 Apr; 40(10):1130-1131. PubMed ID: 35148191
    [No Abstract]   [Full Text] [Related]  

  • 74. Restage and Chemoradiation.
    Dyer BA; Mayadev JS
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):849-850. PubMed ID: 33069349
    [No Abstract]   [Full Text] [Related]  

  • 75. In Regard to Wang et al.
    Ghadjar P; Beck M; Zschaeck S; Wust P
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):855. PubMed ID: 32589993
    [No Abstract]   [Full Text] [Related]  

  • 76. In Reply to Ghadjar et al.
    Wang Y; Chen H
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):856. PubMed ID: 32589994
    [No Abstract]   [Full Text] [Related]  

  • 77. Imaging Study of Pseudo-CT Synthesized From Cone-Beam CT Based on 3D CycleGAN in Radiotherapy.
    Sun H; Fan R; Li C; Lu Z; Xie K; Ni X; Yang J
    Front Oncol; 2021; 11():603844. PubMed ID: 33777746
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Current Status and Perspective of Chemoradiotherapy for Uterine Cervical Cancer].
    Toita T; Ariga T; Kasuya G; Hashimoto S; Maemoto H; Heianna J; Kakinohana Y; Murayama S
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1156-61. PubMed ID: 26489545
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Definitive extended-field intensity-modulated radiotherapy with chemotherapy for cervical cancer with para-aortic nodal metastasis.
    Jung J; Park G; Kim YS
    Anticancer Res; 2014 Aug; 34(8):4361-6. PubMed ID: 25075072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.